Home › Funds › Logos Global Management LP › IMCR

Logos Global Management LP position in IMCR

IMMUNOCORE HLDGS PLC · Health Care

Logos Global Management LP reported holding 600,000 shares of IMCR (IMMUNOCORE HLDGS PLC) in its Q2 2026 13F filing — a position valued at US$19.1M, representing 0.82% of its reported portfolio and ranking #37 among its reported holdings. Logos Global Management LP has disclosed IMCR holdings in 8 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)600.00K sh
Reported value held$19.05M
Portfolio Weight0.82%
First reportedQ3 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Logos Global Management LP's IMCR position evolved

Logos Global Management LP first disclosed a stake in IMCR in Q3 2023 at 450,000 shares (US$23.4M). The position peaked in Q1 2024 at 900,000 shares, worth US$58.5M. Across 8 filings, Logos Global Management LP increased the stake 3 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 600,000 shares valued at US$19.1M — a reduction of -900,000 shares quarter over quarter.. Notable position changes include a 125% increase in Q1 2024 (shares fell 48% over the following quarter), a 76% increase in Q1 2026 (shares rose 5% over the following quarter), a 60% trim in Q2 2026 (shares fell 5% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 450.00K $23.36M New
Q4 2023 400.00K $27.33M Reduce
Q1 2024 900.00K $58.50M Add
Q2 2025 575.00K $18.04M New
Q3 2025 850.00K $30.88M Add
Q4 2025 850.00K $29.50M Hold
Q1 2026 1.50M $45.23M Add
Q2 2026 600.00K $19.05M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IMCR and 13F data

IMCR (IMMUNOCORE HLDGS PLC) is a Health Care company. 31 other funds we track also report a position in IMCR — the largest reported positions include RTW INVESTMENTS, LP (US$154.6M), Bellevue Group AG (US$88.5M), TANG CAPITAL MANAGEMENT LLC (US$84.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IMCR

All IMCR fund holders →

FAQ

How long has Logos Global Management LP held IMCR?

Logos Global Management LP has disclosed IMCR holdings in 8 of the last 12 reported quarters, going back to Q3 2023.

What is Logos Global Management LP's current position in IMCR?

As of Q2 2026, Logos Global Management LP holds 600.00K shares of IMCR (IMMUNOCORE HLDGS PLC), valued at $19.05M, representing 0.82% of its reported portfolio and ranking #37.

Has Logos Global Management LP been buying or selling IMCR?

In the latest 13F filing (Q2 2026), Logos Global Management LP reduced its position in IMCR. The position peaked in Q1 2024 at 900.00K shares.

Which other funds hold IMCR?

Other major institutional holders of IMCR include RTW INVESTMENTS, LP, Bellevue Group AG, TANG CAPITAL MANAGEMENT LLC, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.